Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000893974 | SCV001037939 | likely benign | Polyglandular autoimmune syndrome, type 1 | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001818695 | SCV002071161 | likely benign | not specified | 2020-09-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002275170 | SCV002563701 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | AIRE: BP4, BP7 |
Breakthrough Genomics, |
RCV002275170 | SCV005207503 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000893974 | SCV001464227 | likely benign | Polyglandular autoimmune syndrome, type 1 | 2020-04-29 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004754613 | SCV005351165 | likely benign | AIRE-related disorder | 2024-07-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |